Anthony Chilton

Anthony Chilton is a seasoned senior executive with a strong leadership background in the international life sciences industry, particularly within pharmaceutical and contract service organizations.

With a proven track record of driving business growth and fostering organizational development, Anthony excels in implementing strategic initiatives, managing organizational change, and optimizing cross-functional team dynamics for enhanced operational efficiency.

His expertise spans diverse therapeutic areas, and he possesses a keen interest in ADME/PK, bioanalytical, and preclinical development within the drug discovery and development process.

Anthony holds a PhD in Analytical Chemistry from the University of Hertfordshire and a BSc Hons in Chemistry from the University of East Anglia.

Throughout his career, Anthony has held various key positions, including Chief Strategy Officer at NTxBio, Consultant at BioData Solutions, Founder at C2K2 Consulting Inc, Sr Director at Roivant Sciences, Inc., Consultant at C-Level Management Solutions LLC, CEO/COO at BASi Inc, Senior Director DM/PK at ATHEROGENICS, Vice President at Cardinal Health, SPS, Vice President Research and Bioanalytical Services at Magellan Laboratories, Director, Bioanalytical R/D at Phoenix International, Senior Scientist at Glaxo Smith Kline (GSK), and scientist at Glaxo Inc.